Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
SPX Corp
SPXC
$10.9B
| $35.9M | 0.02% |
508,342
-88,150
| -15% | -$6.25M |
|
452
Sunstone Hotel Investors
SHO
$1.98B
| $35.6M | 0.02% |
3,607,481
-205,160
| -5% | -$2.08M |
|
453
HubSpot
HUBS
$10.9B
| $35.5M | 0.02% |
82,772
-1,910
| -2% | -$697K |
|
454
Quest Diagnostics
DGX
$26.3B
| $35.5M | 0.02% |
250,726
-315,645
| -56% | -$45.2M |
|
|
EXE
455
Expand Energy Corp
EXE
$22.8B
| $35.4M | 0.02% |
+465,535
| New | +$38.3M |
|
|
MRO
456
DELISTED
Marathon Oil Corporation
MRO
| $35.2M | 0.02% |
1,469,352
+1,404,990
| +2,183% | +$35.9M |
|
457
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.5B
| $35.2M | 0.02% |
438,251
+145,159
| +50% | +$11.5M |
|
458
Roivant Sciences
ROIV
$25.5B
| $35.1M | 0.02% |
4,761,438
+4,714,774
| +10,104% | +$38.8M |
|
459
Azenta
AZTA
$1.54B
| $35.1M | 0.02% |
785,927
+17,827
| +2% | +$883K |
|
460
Impinj
PI
$5.37B
| $34.5M | 0.02% |
254,640
+4,590
| +2% | +$585K |
|
461
Axalta
AXTA
$7.96B
| $34.5M | 0.02% |
1,137,748
+144,133
| +15% | +$4.14M |
|
462
Piper Sandler
PIPR
$5.35B
| $34.4M | 0.02% |
991,808
+241,312
| +32% | +$8.6M |
|
|
BKI
463
DELISTED
Black Knight, Inc. Common Stock
BKI
| $34.4M | 0.02% |
596,815
+178,213
| +43% | +$10.7M |
|
464
Verizon
VZ
$196B
| $34.3M | 0.02% |
883,246
-389,860
| -31% | -$15.4M |
|
465
Atlas Energy Solutions
AESI
$1.51B
| $34M | 0.02% |
+1,996,776
| New | +$32.8M |
|
466
NVR
NVR
$17.1B
| $33.6M | 0.02% |
6,033
+5,628
| +1,390% | +$29M |
|
|
DICE
467
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $33.2M | 0.02% |
1,159,664
+66,246
| +6% | +$1.96M |
|
468
Nomad Foods
NOMD
$1.6B
| $33.1M | 0.02% |
1,768,087
-301,877
| -15% | -$5.33M |
|
469
Martin Marietta Materials
MLM
$33.2B
| $33M | 0.02% |
92,987
-9,868
| -10% | -$3.46M |
|
470
Walmart Inc
WMT
$900B
| $33M | 0.02% |
671,595
-393,051
| -37% | -$18.7M |
|
471
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $33M | 0.02% |
432,380
-65,828
| -13% | -$5.46M |
|
|
EGRX
472
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $32.6M | 0.02% |
1,148,429
-81,443
| -7% | -$2.42M |
|
473
4D Molecular Therapeutics
FDMT
$601M
| $32.3M | 0.02% |
1,877,425
+411,158
| +28% | +$8M |
|
474
AutoZone
AZO
$49.7B
| $32.3M | 0.02% |
13,122
-6,925
| -35% | -$16.9M |
|
475
Tenable Holdings
TENB
$4.17B
| $32.1M | 0.02% |
675,114
-121,088
| -15% | -$5.14M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.